Traditional pharmacies 'go dark' on platforms — are consumers the biggest victims?

Shops vanish, patients pay the price

A wave of local complaints in Jinan has put a spotlight on a growing and odd trend: several well‑known chain pharmacies have quietly gone offline on major delivery platforms, leaving customers unable to order urgently needed medicines. One patient reported being unable to find his usual chain on a leading app and having to travel to a community clinic for stomach medicine. Among the companies mentioned in industry reporting are Yangtianhe (养天和) and Shuyu Pingmin Pharmacy (漱玉平民大药房); other big chains cited by analysts include Dashenlin (大参林), Yifeng (益丰), Laobaixing (老百姓) and Yixintang (一心堂). The immediate losers are ordinary consumers who have come to rely on instant delivery for time‑sensitive purchases.

Protest, posture or bad strategy?

Why would brick‑and‑mortar stores cut off a revenue channel that generated substantial online sales for many? The move appears to be a mix of public protest, selective delisting and commercial posturing. It has been reported that at the Xiding conference (西鼎会) some executives publicly attacked platform economics and floated a coordinated delisting as leverage — and it has been reported that they also suggested Beijing might tighten oversight of platform giants. Reportedly, the selective nature of the withdrawals — visible on one platform but not others — suggests the actions are as much about signaling and media attention as about any coherent strategy. Industry data, however, show that O2O services have become a critical growth engine: Shuyu Pingmin's online sales reportedly exceed ¥800 million, Dashenlin's 24‑hour delivery coverage was over 93%, and Yixintang's O2O channel has at times contributed upward of 78% of instant‑retail revenue.

Who wins if channels shrink?

The economic logic warns of unintended consequences. Going dark on platforms shreds a sales channel, weakens bargaining power and, paradoxically, accelerates concentration — if many stores retreat from multi‑platform competition and remain on only a single dominant app, that app's market power grows. Data from Zhongkang CMH show tens of thousands of closures in recent years amid overexpansion and poor customer experience, so the real problem for many chains is internal: legacy sales models, opaque pricing and weak service. Platforms have already moved to patch supply gaps and defend users, but the broader lesson is stark: in China's fast‑moving instant‑retail market, token resistance to digital channels risks alienating the very customers pharmacies need most. If the goal is to protect consumers and long‑term business, shouldn’t pharmacies fix their service and compete — rather than go dark?